Hashemkhani et al. [56] used cetuximab-conjugated Ag2S-2MPA (AS-2MPA) quantum dots that emit NIR emission to act as theranostic agents in targeted ALA-PDT treatment and chemotherapy combination therapy of EGFR-positive colorectal cancer. Here, EGFR is linked to colorectal cancer.